Extended dosage interval of B-cell therapy in multiple sclerosis

Autor:	Frederik Novak, Ostergaard, K., Munksgaard Berg, J., Hilt Kristensen, C., Zsolt Illes, Sellebjerg, F., Tobias Sejbaek
Zdroj:	University of Southern Denmark Novak, F, Ostergaard, K, Berg, J M, Kristensen, C H, Illes, Z, Sellebjerg, F & Sejbaek, T 2021, ' Extended dosage interval of B-cell therapy in multiple sclerosis ', Multiple Sclerosis Journal, vol. 27, no. Suppl. 2, pp. 767 . < https://doi.org/10.1177/13524585211047080 > Novak, F, Østergaard, K, Berg, J M, Kristensen, C H, Illes, Z, Sellebjerg, F & Sejbaek, T 2021, ' Extended dosage interval of B-cell therapy in multiple sclerosis ', Multiple Sclerosis Journal, vol. 27, no. Suppl. 2, P941, pp. 767 . https://doi.org/10.1177/13524585211047080
DOI:	10.1177/13524585211047080
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::86c1d22b9f7ba0b9068c18a2ecfe5758 https://portal.findresearcher.sdu.dk/en/publications/f0219333-aa58-4bcb-bb9d-2a2d4154e39f Zobrazit plný text záznamu